• Offer by company and Sackler family valued at up to $12bn
  • If deal collapses, company likely to file for bankruptcy

Purdue Pharma, the maker of OxyContin, was nearing a partial agreement on Wednesday to resolve widespread litigation over its alleged role in fueling the US opioids crisis, and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said.

Late on Tuesday, lead lawyers representing more than 2,000 cities, counties and other plaintiffs suing prescription painkiller manufacturer Purdue, along with more than two dozen states and US territories, were close to agreeing on an offer from the company and members of its controlling Sackler family to settle lawsuits in a deal valued at up to $12bn, the people said.

Continue reading…

Read More Purdue Pharma believed to be close to partial settlement in opioids case

Facebook Comments